Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hydrumedical develops advanced medical devices with a primary focus on biodegradable ureteral stents ("HydrUStent") that eliminate the need for a second surgery by naturally degrading after use. This innovation reduces healthcare costs and improves patient outcomes by minimizing hospital admissions and facilitating faster recovery. The company's expertise includes natural-origin polymer processing and biopolymer-based medical devices targeting urology and related fields. They also provide consulting, testing, regulatory affairs support, and prototype-to-clinical sample manufacturing services in ISO cleanroom environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hydrumedical.